Detection of Mild Cognitive Impairment Using In‐clinic and Remote Unsupervised Digital Cognitive Assessments

The Cogstate Brief Battery (CBB) is a computerized cognitive assessment validated for Alzheimer’s disease (AD) and unsupervised use. The CBB assesses processing speed, attention, visual learning, and working memory and is offered to cognitively normal (CN) and mild cognitive impairment (MCI) participants in ADNI‐3. In‐clinic visits are completed annually for MCI and every other year for CN, with both groups also able to complete unsupervised assessments at‐home within 14 days of the first in‐clinic visit and at up to 3 monthly intervals.